Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Category

Sub-category

Conference

Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in...

Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA

Gemcitabine, cisplatin plus nivolumab achieves clinical complete response in subset of muscle-invasive bladder cancer patients ( Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA )

Adjuvant nivolumab as standard of care for high-risk muscle-invasive urothelial...

Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA

Adjuvant nivolumab as standard of care for high-risk muscle-invasive urothelial carcinoma after radical resection ( Prof Matt Galsky - Icahn School of Medicine at Mount Sinai, New York City, USA )

ASCO GU 2023: Latest real world data in prostate cancer

Prof Phil Cornford and Prof Laura-Maria Krabbe

ASCO GU 2023: Latest real world data in prostate cancer ( Prof Phil Cornford and Prof Laura-Maria Krabbe )

Treatment sequencing for patients with mCRPC

Prof Axel Merseburger and Prof Stéphane Oudard

Treatment sequencing for patients with mCRPC ( Prof Axel Merseburger and Prof Stéphane Oudard )

Hypofractionated high dose intensity modulated radiotherapy non-inferior for...

Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK

$Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer ( Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK )$

JAVELIN Bladder 100: Avelumab maintenance indicated as a standard of care for...

Dr Srikala Sridhar - Princess Margaret Cancer Centre, Ontario, Canada

JAVELIN Bladder 100: Avelumab maintenance indicated as a standard of care for advanced urothelial carcinoma ( Dr Srikala Sridhar - Princess Margaret Cancer Centre, Ontario, Canada )

Safety and efficacy of immune checkpoint inhibitors in advanced penile squamous...

Dr Talal El Zarif - Dana-Farber Cancer Institute, Boston, USA

Safety and efficacy of immune checkpoint inhibitors in advanced penile squamous cell carcinoma ( Dr Talal El Zarif - Dana-Farber Cancer Institute, Boston, USA )

HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer

Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain

HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer ( Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain )

Choosing Wisely in haemato oncology and medical oncology

Dr Omar Hamid - Garissa Cancer Center, Garissa, Kenya

Choosing Wisely in haemato oncology and medical oncology ( Dr Omar Hamid - Garissa Cancer Center, Garissa, Kenya )

Choosing Wisely in haemato-medical oncology

Dr Omar Hamid - Garissa Cancer Centre, Garissa, Kenya

Choosing Wisely in haemato-medical oncology ( Dr Omar Hamid - Garissa Cancer Centre, Garissa, Kenya )

Choosing Wisely campaigns in Africa

Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda

Choosing Wisely campaigns in Africa ( Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda )

Trifluridine/tipiracil plus bevacizumab improves OS in mCRC

Dr Josep Tabernero - Vall d’Hebron University Hospital, Barcelona, Spain

Trifluridine/tipiracil plus bevacizumab improves OS in mCRC ( Dr Josep Tabernero - Vall d’Hebron University Hospital, Barcelona, Spain )

More from ecancer